88 related articles for article (PubMed ID: 26111905)
41. The global burden of chronic kidney disease: estimates, variability and pitfalls.
Glassock RJ; Warnock DG; Delanaye P
Nat Rev Nephrol; 2017 Feb; 13(2):104-114. PubMed ID: 27941934
[TBL] [Abstract][Full Text] [Related]
42. Urbanization and kidney function decline in low and middle income countries.
Jagannathan R; Patzer RE
BMC Nephrol; 2017 Aug; 18(1):276. PubMed ID: 28851306
[TBL] [Abstract][Full Text] [Related]
43. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
44. Burden of chronic kidney disease and its risk factors in Malaysia.
Begum R; Khan TM; Ming LC
J Epidemiol Glob Health; 2016 Dec; 6(4):325-326. PubMed ID: 27095074
[No Abstract] [Full Text] [Related]
45. Sex differences in the relationship between leukocyte count and chronic kidney disease: the 2007 Korean National Health and Nutrition Examination Survey.
Na HY; Shim JY; Lee HR; Jung DH; Kim HB; Park BJ; Jung RJ; Lee YJ
J Womens Health (Larchmt); 2011 Jan; 20(1):99-105. PubMed ID: 21194272
[TBL] [Abstract][Full Text] [Related]
46. Response to Letter Regarding Article, "Estimated Global, Regional, and National Disease Burdens Related to Sugar-Sweetened Beverage Consumption in 2010".
Singh GM; Micha R; Khatibzadeh S; Lim S; Ezzati M; Mozaffarian D
Circulation; 2016 Apr; 133(15):e596. PubMed ID: 27067092
[No Abstract] [Full Text] [Related]
47. Obesity and kidney disease.
Lim AK
Aust Fam Physician; 2006 Oct; 35(10):759. PubMed ID: 17061351
[No Abstract] [Full Text] [Related]
48. [Economic impact of the chronic kidney disease: Perspective of the Instituto Mexicano del Seguro Social].
Cortés-Sanabria L; Álvarez-Santana G; Orozco-González CN; Soto-Molina H; Martínez-Ramírez HR; Cueto-Manzano AM
Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S124-32. PubMed ID: 29697222
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
Ji E; Kim YS
Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
[TBL] [Abstract][Full Text] [Related]
50. Sugar-sweetened beverage consumption is linked to global adult morbidity and mortality through diabetes mellitus, cardiovascular disease and adiposity-related cancers.
Ruff RR
Evid Based Med; 2015 Dec; 20(6):223-4. PubMed ID: 26442567
[No Abstract] [Full Text] [Related]
51. Letter by Mullie et al Regarding Article, "Estimated Global, Regional, and National Disease Burdens Related to Sugar-Sweetened Beverage Consumption in 2010".
Mullie P; Autier P; Boyle P
Circulation; 2016 Apr; 133(15):e595. PubMed ID: 27067091
[No Abstract] [Full Text] [Related]
52. Chronic kidney disease in disadvantaged populations.
Garcia-Garcia G; Jha V;
Braz J Med Biol Res; 2015 May; 48(5):377-81. PubMed ID: 25760025
[TBL] [Abstract][Full Text] [Related]
53. Effect of Anemia on Physical Function and Physical Activity in CKD: The National Health and Nutrition Examination Survey, 1999-2016.
Farag YMK; Blasco-Colmenares E; Zhao D; Sanon M; Guallar E; Finkelstein FO
Kidney360; 2023 Sep; 4(9):e1212-e1222. PubMed ID: 37768811
[TBL] [Abstract][Full Text] [Related]
54. Capsule Commentary on Kurani et al., Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011-2016.
Machen J
J Gen Intern Med; 2020 Apr; 35(4):1362. PubMed ID: 32076972
[No Abstract] [Full Text] [Related]
55. Disease burden and challenges of chronic kidney disease in North and East Asia.
Wang J; Zhang L; Tang SC; Kashihara N; Kim YS; Togtokh A; Yang CW; Zhao MH;
Kidney Int; 2018 Jul; 94(1):22-25. PubMed ID: 29573819
[No Abstract] [Full Text] [Related]
56. What is the true burden of chronic kidney disease in children worldwide?
Harambat J; Madden I
Pediatr Nephrol; 2023 May; 38(5):1389-1393. PubMed ID: 36409363
[No Abstract] [Full Text] [Related]
57. Reducing the Burden of CKD among Latinx: A Community-Based Approach.
Pereira RI; Cervantes L
Clin J Am Soc Nephrol; 2021 May; 16(5):812-814. PubMed ID: 33441466
[No Abstract] [Full Text] [Related]
58. The One-Two-Three Punch: Exposure, Susceptibility, and Disease Burden among U.S. Populations of Color.
Seltenrich N
Environ Health Perspect; 2022 Mar; 130(3):34001. PubMed ID: 35254865
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology of chronic kidney disease: an update 2022.
Kovesdy CP
Kidney Int Suppl (2011); 2022 Apr; 12(1):7-11. PubMed ID: 35529086
[TBL] [Abstract][Full Text] [Related]
60. An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.
Delanaye P; Glassock RJ; Pottel H; Rule AD
Clin Biochem Rev; 2016 Feb; 37(1):17-26. PubMed ID: 27057075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
